This was Future Medicine 2018

What does the future of medicine look like? How are life sciences progressing? Which impact do AI and digitalization have on medical research? Which challenges is the health system facing?

The audience learned about the answers to these questions at the third Future Medicine Conference in Berlin on November 7, 2018.

Future Medicine Science Match at a glimpse

• The unique format "Science Match" was created by Tagesspiegel and brings together innovation and science

• Four main topics

• Up to 80 scientists present their current research in just 3 minutes

• "Meet The Speakers": After each session, participants have the chance to talk to the speakers, ask questions and exchange knowledge

• Young Changers: We invite up to 100 Students and Young Professionals to join the conference by a Young Changers scholarship.

The Organisers

Tagesspiegel and Berlin Institute of Health, together with Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, featured outstanding international scientists, great visions of the future of medicine, and an exceptional concentration of knowledge.

About Berlin Institute of Health (BIH)

Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine. BIH is dedicated to improving the prediction in progressive diseases and developing advanced therapies for unmet medical needs in order to improve patients’ health and quality of life. The Institute is committed to providing excellent research solutions and innovation enabling value-based, personalized healthcare. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), are independent member entities within BIH.

Scientific Program Committee

• Prof Ulrich Dirnagl

Founding Director of the BIH QUEST Center for Transforming Biomedical Research

About Future Medicine Science Match

About 80 top scientists from leading Berlin institutions and international partners presented cutting-edge translational medicine and gave an insight into their work in short 3-minute presentations. Attracting up to 800 participants, the target audiences of this event were academics, young professionals, healthcare industry, venture capital, funding institutions and policy makers.